In an outbreak of Salmonella Paratyphi B var. L(+) tartrate+ an additional patient has been identified, bringing the total to 37, compared to 36 a week ago. The FDA has not released any information about the patients. The FDA first posted the outbreak on June 14. No source has been identified for the pathogen. The FDA has initiated product traceback, sample analysis and onsite inspections, but the agency has not reported what food is being traced or sampled. It has also not reported what location is being inspected.

In an outbreak of Cyclospora cayetanensis the patient count has increased to 55, up from 47 reported a week ago. The FDA has not released any information about the patients. The FDA first reported the outbreak on July 27. The agency has initiated traceback and onsite inspection, but has not reported what food is being traced or what location is being inspected.

In two other outbreaks of Cyclospora infections the FDA is reporting that patient counts are holding steady compared to this past week with 140 and 69 patients reported. In the smaller outbreak the FDA has initiated product traceback, sample analysis and onsite inspections, but the agency has not reported what food is being traced or sampled. It has also not reported what location is being inspected. In the larger outbreak the FDA has initiated traceback and onsite inspections but has not reported what food it is tracing or what location it is inspecting. 

In an outbreak of E. Coli 026 involving 13 patients the FDA has initiated traceback but has not reported what food is being traced. The agency first posted the outbreak on July 26. It has not released any patient information.